Company / Cash per Share
Tango Therapeutics, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.04
FY2025
5-year range
$0.68 / $3.54
FY2021-FY2025
Trend
+53.2%
vs FY2024
Sector context
#148 of 205
Health Care
What the data says
At $1.04, Tango Therapeutics, Inc.'s cash per share ranks #148 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 6 years, ranging from $0.68 in FY2024 to $3.54 in FY2021.
Based on SEC 10-K filings.
1.04 in FY2025 with a 5-year CAGR of +3.2%.
Improved from $0.75 to $1.04 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +15.0%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
#148 of 205 in Health CareTop 72% of 205This company $1.04 Sector average $72.93
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 53.2% year-over-year.
- Ranks #148 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.04 | +53.2% |
| FY2024 | $0.68 | -9.6% |
| FY2023 | $0.75 | +9.8% |
| FY2022 | $0.69 | -80.6% |
| FY2021 | $3.54 | +297.8% |
| FY2020 | $0.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026